Tenecteplase — Drug Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

5 Recruiting

2 Completed trials

8 Sponsors

16 Countries

Phase III

Phase II

Phase IV

Phase III: 8 Phase II: 1 Phase IV: 1

Indications tested

Ischaemic stroke 2

Sponsors using this IMP

Insel Gruppe AG 2 Oslo University Hospital HF 2 Assistance Publique Hopitaux De Paris 1 Boehringer Ingelheim International GmbH 1 Centre Hospitalier Regional Universitaire De Tours 1 Universitaetsklinikum Heidelberg AöR 1 Universitaetsklinikum Tuebingen AöR 1 University Medical Center Hamburg-Eppendorf 1

All trials

10 total

Extending the time window for Tenecteplase by Effective RecanalizatioN of bAsilar artery occLusion in patients with POSTerior circulation st… Pending

2024-513444-28-00 Phase III 1 country Centre Hospitalier Regional Universitaire De Tours
“Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicen… Pending

2024-520414-21-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A study to test if tenecteplase helps people to recover from an acute stroke when given more than 4.5 hours after the person was last seen w… Pending

2025-522542-40-00 Phase III 6 countries Boehringer Ingelheim International GmbH
TENECTEPLASE IN CENTRAL RETINAL ARTERY OCCLUSION STUDY (TenCRAOS): A Prospective, randomised-controlled, double-dummy, double-blind phase 3 … Recruiting

2024-517606-29-00 Phase III 6 countries Oslo University Hospital HF
Local Tenecteplase ApplicatiOn subsequent to endovasCular Recanalization in Anterior CircuLation Stroke - the LOCAL trial Recruiting

2024-516544-26-00 Phase II 1 country Universitaetsklinikum Heidelberg AöR
Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants Recruiting

2025-521762-99-00 Phase III 1 country University Medical Center Hamburg-Eppendorf
Safety and Efficacy of Intravenous Thrombolysis in Patients with Ischemic Stroke on Treatment with Direct Oral Anticoagulants: DO-IT – The D… Recruiting

2024-515561-34-01 Phase IV 9 countries Insel Gruppe AG
Thrombolysis in Factor Xa-inhibitors Trial (SIFT) Recruiting

2023-509907-34-01 Phase III 3 countries Oslo University Hospital HF
Safety and Efficacy of intra-arterial Tenecteplase for non-complete reperfusion of intracranial occlusion Ended

2022-502878-16-00 Phase III 6 countries Insel Gruppe AG
Early Reperfusion Therapy for Recovery of Vision in Acute Central Retinal Artery Occlusion Ended

2023-507388-21-00 Phase III 1 country Universitaetsklinikum Tuebingen AöR

Showing 1–10 of 10 trials

← All drugs A–Z